Haemonetics (HAE) Other Non-Current Liabilities (2010 - 2026)

Haemonetics' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $59.4 million for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 12.91% year-over-year to $59.4 million in Q1 2026; TTM through Mar 2026 was $59.4 million, a 12.91% decrease from a year earlier, with the FY2026 full-year figure at $59.4 million, down 12.91% from the prior year.
• Other Non-Current Liabilities fell to $59.4 million in Q1 2026 per HAE's latest filing, from $63.6 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $92.3 million in Q2 2024 and bottomed at $59.4 million in Q1 2026.
• The 5-year median for Other Non-Current Liabilities is $74.9 million (2023), against an average of $75.7 million.
• Across the five-year window, Other Non-Current Liabilities climbed 28.71% in 2024 and slipped 29.3% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $78.2 million in 2022, then fell by 2.51% to $76.3 million in 2023, then rose by 17.97% to $90.0 million in 2024, then declined by 29.3% to $63.6 million in 2025, then slipped by 6.62% to $59.4 million in 2026.
• Per Business Quant, the three latest HAE Other Non-Current Liabilities figures stand at $59.4 million (Q1 2026), $63.6 million (Q4 2025), and $66.1 million (Q3 2025).